India Approves Biovigilance Programme for Safer Organ Transplant Products

The Indian government approved a new programme to make organ and tissue transplants safer.

It will watch for harmful problems caused by medicines and biological products used during transplants.

The programme will cover both donors and people receiving organs or tissues.

The Indian Pharmacopoeia Commission will lead this work.

It will work alongside programmes that monitor medicines and medical devices.

The government wants doctors, patients and others to report safety problems.

It also plans to use mobile apps, artificial intelligence and data analysis to improve reporting.

Officials said better reporting can help prevent harm and save lives.